Tenaya Therapeutics
PublicTenaya Therapeutics is now publicly traded
The data on this page reflects Tenaya Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jul 30, 2021
Last Round
Follow-on Offering
Dec 15, 2025
Total Funding Raised
$626.7M
Company Overview
Tenaya Therapeutics (NAS: TNYA) is a biotechnology company dedicated to discovering and developing curative therapies targeting the root causes of heart disease through gene therapy, cellular regeneration, and precision medicine.
Sector
Healthcare
AI Layer
Non-AI
Keywords
Tenaya Therapeutics Comparables
Compare Tenaya Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affinia Therapeutics | 77% | |
| AaviGen | 74% | |
| Nuevocor | 74% |
Tenaya Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Dec 15, 2025 | ||||
| Follow-on Offering | Mar 5, 2025 | ||||
| Grant | Feb 3, 2025 | ||||
| Follow-on Offering | Feb 8, 2024 | ||||
| Grant | Jun 24, 2022 | ||||
IPO | Jul 30, 2021 |
Tenaya Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series C, Follow-on Offering, Series B, Series A |
| Soleus Capital | Follow-on Offering |
| RA Capital Management | Follow-on Offering, Series C |
| GV | Series C, Series B |
| Waycross Ventures | Series C |
| Integral Health Asset Management | Follow-on Offering |
| Fidelity Management & Research Company | Series C |
Tenaya Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access